Paloma Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9,221
Closed -$379K 1731
2021
Q1
$379K Buy
9,221
+1,932
+27% +$72K 0.01% 1326
2020
Q4
$212K Sell
7,289
-5,732
-44% -$148K 0.01% 1350
2020
Q3
$287K Buy
+13,021
New +$332K 0.01% 1512
2018
Q3
Sell
-18,845
Closed -$373K 1489
2018
Q2
$373K Buy
+18,845
New +$414K 0.01% 1166
2016
Q2
Sell
-3,905
Closed -$44K 2126
2016
Q1
$44K Buy
+3,905
New +$39.9K ﹤0.01% 1799
2015
Q2
Sell
-3,776
Closed -$36K 1761
2015
Q1
$36K Sell
3,776
-2,953
-44% -$30.5K ﹤0.01% 1157
2014
Q4
$69K Buy
6,729
+3,097
+85% +$26.9K ﹤0.01% 1084
2014
Q3
$29K Buy
+3,632
New +$27.3K ﹤0.01% 967

Other funds holding ACLS

Paloma Partners's ACLS Position: Q2 2021 in Review

Paloma Partners sold out of Axcelis (ACLS) in Q2 2021, closing a stake of 9,221 shares — an estimated $379K sold.

Paloma Partners first reported a position in ACLS in Q3 2014 and held it in 8 quarters. The position peaked at $379K in Q1 2021. 189 funds tracked by Wall St. Rank hold ACLS as of Q2 2021.

  • Paloma Partners reported no remaining Axcelis position as of Q2 2021 after selling out during the quarter.
  • Paloma Partners sold 9,221 Axcelis shares in Q2 2021, an estimated $379K.
  • Paloma Partners first reported a position in Axcelis in Q3 2014 and held it in 8 quarters.
  • Paloma Partners's Axcelis position peaked at $379K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Axcelis as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.